Platform Acquisition Holdings Limited to Acquire MacDermid, Incorporated for $1.8 Billion

 Platform Acquisition Holdings Limited to Acquire MacDermid, Incorporated for
                                 $1.8 Billion

  PR Newswire

  TORTOLA, British Virgin Islands, Oct. 10, 2013

- Combined entity to be named Platform Specialty Products Corporation

- Transaction is first significant milestone in building a portfolio of
industry-leading, best-in-class specialty chemical verticals

- Conference call to be held at 9:00 a.m. (Eastern) Friday, October 11;
details at end of release

TORTOLA, British Virgin Islands, Oct. 10, 2013 /PRNewswire/ -- Platform
Acquisition Holdings Limited (LSE: PAH) ("Platform") has entered into a
definitive agreement to acquire MacDermid, Incorporated ("MacDermid" or "the
Company"), a global provider of high value-added specialty chemicals for
approximately $1.8 billion plus contingent consideration. Platform will be
renamed Platform Specialty Products Corporation ("PSP"). Following the close
of the transaction, PSP expects to complete a listing of its shares on the New
York Stock Exchange by the end of 2013. Platform's shares and warrants have
been suspended from trading on the London Stock Exchange and it is not
expected that trading will resume. It is anticipated that Platform's listing
of shares and warrants on the London Stock Exchange will be cancelled on or
shortly after the New York Stock Exchange listing is achieved.

MacDermid is a global specialty chemicals company that has offered its
customers innovative, dynamic chemistry solutions and technical services for
more than 90 years, establishing leading positions in niche segments. The
Company serves over 3,500 customers in 24 countries across the electronics,
graphic arts, metals, oil production and drilling and plastics finishing
industries. MacDermid's innovative culture and core strengths in R&D and
technical service accelerate growth and drive margins, while its low fixed
cost structure creates resilience through economic cycles.

MacDermid has delivered consistent and strong financial results, including an
estimated $742 million in sales and $180 million in adjusted EBITDA for the
twelve months ended September 30, 2013. In addition, the Company maintains a
robust margin profile, including an estimated gross margin of 51.0% and an
estimated adjusted EBITDA margin of 24.3% over the same period. MacDermid
generated $148 million in free cash flow in 2012, with a cash conversion ratio
of 91.1%. The business historically requires minimal capital expenditures,
typically less than 2% of revenue.

MacDermid will continue to be operated as a standalone business by its
existing management team under the PSP umbrella. At closing, Platform intends
to change the composition of its Board in anticipation of its move from the
London Stock Exchange to the New York Stock Exchange. The reconstituted Board
of Directors will consist of a deep bench of talent with expertise and
experience in building best-in-class public companies and positioning them for
success. Martin E. Franklin, Founder and Executive Chairman of Jarden
Corporation, will serve as PSP's Chairman, to provide ongoing strategic
guidance over the long term. MacDermid's existing executive team will become
PSP's new executive team. MacDermid's Chairman and Chief Executive Officer
Daniel Leever will become PSP's CEO and Vice Chairman. During Mr. Leever's 35
year tenure at MacDermid, the Company's revenues have increased five-fold and
firm value increased 20 fold through strong organic growth complemented by
strategic acquisitions. Frank Monteiro, MacDermid's Chief Financial Officer,
will become the CFO of PSP.

Martin E. Franklin, Platform's Founder and Director, said, "As we look to
build a portfolio of market-leading specialty chemicals businesses, MacDermid
is a natural choice to serve as the initial investment and foundation for
Platform Specialty Products. MacDermid's heritage and market presence make it
a leader within the sector, and this transaction will provide the Company with
the tools and resources necessary to reach the next level of success. We will
maintain and respect the integrity of the seasoned and skilled management team
as well as the MacDermid brand, products and operations, which have achieved
consistent and impressive growth. We look forward to this being a successful,
long-term partnership and are confident that this transaction will be the
first of many milestones we will achieve together."

Dan Leever, MacDermid's Chairman and Chief Executive Officer, commented, "I'm
delighted that MacDermid has found a permanent home from which we can achieve
our long-term vision of being a leading global specialty chemicals company.
Our business is characterized by a blended chemistry manufacturing model that
is inherently non-capital intensive and requires high levels of innovation and
technical service. This 'asset-lite, high-touch' business model enables us to
deliver results to a diversified customer base, resulting in significant free
cash flow to support organic growth and growth through acquisitions. Our
ability to adapt our technology to changing market trends and demands provides
resilience and a robust pipeline for growth. We will continue to execute on
this flexible, yet stable model, and are confident the added resources from
this transaction will accelerate our growth trajectory. I'd like to thank all
of MacDermid's employees for their ongoing dedication and know that they all
share in my excitement as we enter into a new, transformative phase."

"Platform was extremely disciplined in reviewing potential opportunities,"
commented Lord Myners, the independent Chairman of Platform's Board of
Directors, adding that, "The MacDermid transaction offers a compelling
financial profile and strategic fit that is solidly in line with our
acquisition criteria. The Board voted unanimously in favor of entering into
the business combination agreement. We look forward to closing the transaction
shortly and recommencing trading once the requirements of the U.S. Securities
and Exchange Commission and The New York Stock Exchange are satisfied."

The transaction is expected to be funded through proceeds from Platform's
previously completed IPO, an amendment of MacDermid's existing first lien term
debt and proceeds from a warrant exchange offer to be carried out by Platform.
After giving effect to the transaction, the Company net debt to EBITDA
leverage ratio is expected to be less than 4X. The transaction is expected to
close by the end of October 2013, subject to customary closing conditions.

Barclays acted as financial advisor and Greenberg Traurig acted as legal
advisor to Platform on the transaction. Lazard acted as financial advisor to
the seller.

Conference Call Information

Platform will be hosting a conference call at 9:00 a.m. ET on Friday, October
11, 2013 to discuss the transaction. The call can be accessed by dialing
1-800-762-8779 for U.S. callers, 0800-358-5271 for U.K. callers or
+1-480-629-9645 for international callers and referencing the pass code:
4645143. An audio replay will be available on Platform's website, .

A slide presentation will be available at .

Safe Harbor

Forward-Looking Statements and Disclaimers

This announcement does not constitute or form part of any offer or invitation
to purchase, otherwise acquire, issue, subscribe for, sell or otherwise
dispose of any securities, nor any solicitation of any offer to purchase,
otherwise acquire, issue, subscribe for, sell, or otherwise dispose of any

This announcement is not an offer of securities for sale or a solicitation of
an offer to purchase securities of Platform.

The release, publication or distribution of this announcement in certain
jurisdictions may be restricted by law and therefore persons in such
jurisdictions into which this announcement is released, published or
distributed should inform themselves about and observe such restrictions.

Barclays is acting exclusively for Platform and no one else in connection with
the transaction and will not be responsible to anyone other than Platform for
providing the protections afforded to its clients or for providing advice in
relation to the transaction or in relation to the contents of this
announcement or any transaction or any other matters referred to herein.
Barclays Bank PLC is authorized by the Prudential Regulation Authority and
regulated by the Financial Conduct Authority and the Prudential Regulation

Certain statements in this announcement are forward-looking statements which
are based on the Company's expectations, intentions and projections regarding
its future performance, anticipated events or trends and other matters that
are not historical facts, including expectations regarding (i) the closing
date of the transaction, (ii) the date by which Platform shares will be listed
on the New York Stock Exchange, (iii) the benefits of the MacDermid technology
and strategy and its impact on MacDermid's future financial performance and
(iv) the future operating and financial performance of PSP. These statements
are not guarantees of future performance and are subject to known and unknown
risks, uncertainties and other factors that could cause actual results to
differ materially from those expressed or implied by such forward-looking
statements, including (i) the ability of Platform to have a registration
statement declared effective by the SEC, (ii) the ability of Platform to meet
the NYSE listing criteria, (iii) the ability and willingness of all parties to
the definitive agreement to meet the closing conditions set forth in the
agreement and (iv) economic conditions, competition and other risks that may
affect MacDermid's future performance. Given these risks and uncertainties,
prospective investors are cautioned not to place undue reliance on
forward-looking statements. Forward-looking statements speak only as of the
date of such statements and, except as required by applicable law, the Company
undertakes no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or

About MacDermid

MacDermid Inc. is a leading global producer of high technology, specialty
chemical products and a provider of technical services. For more than 90
years, MacDermid has manufactured dynamic chemistries, through the blending of
raw materials in complex, innovative multi-step technological processes.
MacDermid operates in two segments, Performance Materials and Graphic
Solutions, serving 3,500 customers in 24 countries across the electronics,
graphic arts, metals, oil production and drilling and plastics finishing
industries. Established in 1922 and headquartered in Denver, Colorado,
MacDermid employs over 2,000 people in 38 sites and facilities in 24
countries. Additional information on MacDermid and its products and services
is available at .

About Platform Acquisition Holdings

Platform Acquisition Holdings Limited (LSE: PAH) operates as a publicly listed
acquisition company and completed its IPO in May 2013. The Company was formed
to undertake an acquisition of a target company or business with an expected
enterprise value of between $750 million and $2.5 billion and to operate the
acquired business and implement an operating strategy with a view to
generating value for shareholders. More information on Platform Acquisition
Holdings is available at .

Note: This release contains non-GAAP financial measures that may not be
directly comparable to other similarly titled measures used by other
companies. For purposes of Regulation G, a non-GAAP financial measure is a
numerical measure of a company's historical or future financial performance,
financial position or cash flows that excludes amounts, or is subject to
adjustments that have the effect of excluding amounts, that are included in
the most directly comparable measure calculated and presented in accordance
with GAAP in the statements of operations, balance sheets, or statements of
cash flows of the Company; or includes amounts, or is subject to adjustments
that have the effect of including amounts, that are excluded from the most
directly comparable measure so calculated and presented. Pursuant to the
requirements of Regulation G, the Company has provided reconciliations of the
non-GAAP financial measures to the most directly comparable GAAP financial
measures. These non-GAAP measures are provided because management of the
Company uses these financial measures in monitoring and evaluating the
Company's ongoing financial results and trends. Management uses this non-GAAP
information as an indicator of business performance, and evaluates overall
management with respect to such indicators.

This announcement is not a prospectus and not an offer for sale, or a
solicitation of an offer to acquire, securities in any jurisdiction including
in or into the United States, Canada, Australia, or Japan. Investors should
not subscribe for or purchase any transferable securities referred to in this
announcement except on the basis of information in the Registration Statement
intended to be filed by Platform Acquisition Holdings Limited in due course in
connection with the registration of its shares with the U.S. Securities and
MATTERS. Copies of the Registration Statement will, following its filing, be
available on the website of the SEC at .

Platform will file with the SEC a registration statement on Form S-4
containing a prospectus with respect to the securities to be offered to
certain shareholders of MacDermid and those securities to be listed on the New
York Stock Exchange (the "Prospectus"). PLATFORM SHAREHOLDERS AND THOSE
shareholders will be able to obtain free copies of the Prospectus and other
documents filed with the SEC by Platform through the website maintained by the
SEC at .

Schedule to Release

MacDermid Incorporated
Reconciliation of Non-GAAP measures
(Note: numbers in millions USD)                       (Unaudited )
ADJUSTED EBITDA                                                     LTM
                                                  2012           Sept 2013
Net income (loss)                                       $46.0           $39.7
Adjustments to reconcile to net income
Income tax expense (benefit)                             24.6            26.9
Interest expense                                         49.7            40.3
Depreciation and amortization expense                    42.2            40.4
Unrealized gain on foreign currency
denominated debt                                        (5.7)             2.6
Equity based compensation expense                         0.2             3.4
Restructuring and related non recurring
expenses                                                  1.2             2.9
Non cash intangible impairment charges                      -             0.4
Other non recurring expenses                              4.2            23.4
Income (loss) from discontinued operations                  -               -
Adjusted EBITDA                                        $162.4          $180.0
Other non-recurring expenses include expenses related to a project to pursue
a public offering and to the 2013 debt recapitalization
Adjusted EBITDA                                        $162.4
Adjustments related to cash flow:
Gross capital expenditures (1)                           13.4
Change in net working capital (calculated
below)                                                    1.5
Free cash flow                                         $147.5
Cash conversion ratio (Free cash flow
divided by Adjusted EBITDA)                               0.9
Gross capital expenditures do not include
any offsets for asset sales
                                                   As of December 31,
NET WORKING CAPITAL                               2011             2012
Accounts receivable, net                               $134.6          $139.0
Inventory, net                                           75.2            76.1
Prepaid expenses                                         12.0            10.9
Accounts payable, net                                  (49.5)          (53.4)
Accrued expenses, net                                  (37.4)          (36.1)
Net working capital                                    $135.0 $136.5

Media Contacts:

Liz CohenWeber Shandwick +1-212-445-8044

Kelly GawlikWeber Shandwick +1-212-445-8368

John MoriartyWeber Shandwick +44 (0)207 067 0736

Press spacebar to pause and continue. Press esc to stop.